70) n schemes prior to cell culture, cytokine/growth factor cocktails, the impact of bio |
71) Epidermal growth factor (EGF) and fibroblast growth |
72) Activating fibroblast growth factor (FGF) signals and inhibiting |
73) embryology that members of the fibroblast growth factor (FGF), transforming growth f |
74) loped by two concentrations of hepatocyte growth factor (HGF) and oncostatin M (OSM) |
75) iated by c-MET and its ligand, hepatocyte growth factor (HGF), has been implicated i |
76) 0001) was observed on plasma insulin-like growth factor (IGF)-I concentrations. |
77) age 4, EnSCs were induced by keratinocyte growth factor (KGF) and epidermal growth f |
78) illustrated that, in the absence of nerve growth factor (NGF), PC12 cells increased |
79) th 6 days after administration of nerve growth factor (NGF). |
80) topical applications of platelet-derived growth factor (PDGF) on the healing of isc |
81) was mediated in part by platelet-derived growth factor (PDGF) signalling. |
82) noviral vectors carrying the transforming growth factor (TGF) β3 gene were selected |
83) co-delivered - the gene for transforming growth factor (TGF)β3, to facilitate SMSC |
84) Expression of b-FGF, vascular endothelial growth factor (VEGF) and matrix metallopro |
85) rovessel density and vascular endothelial growth factor (VEGF) levels. |
86) ession, induction of vascular endothelial growth factor (VEGF) synthesis, nitric oxi |
87) Increased serum vascular endothelial growth factor (VEGF), complement component |
88) rdiac expressions of vascular endothelial growth factor (VEGF)-D and matrix metallop |
89) ound to downregulate vascular endothelial growth factor (VEGF)/phosphorylated forms |
90) ced the secretion of vascular endothelial growth factor (VEGF, also known as vascula |
91) ne expression changes of basic fibroblast growth factor (b-FGF), vascular endothelia |
92) Recombinant human epithelial growth factor (rhEGF) was selected as a mo |
93) sensitivity to estradiol and insulin-like growth factor 1 (IGF1), as measured in gro |
94) ansfected with human vascular endothelial growth factor 165 (VEGF-165) or human stro |
95) regulates the expression of insulin-like growth factor 2 (IGF2), which has a critic |
96) these compounds, whereas the recombinant growth factor Activin A could force the di |
97) ng to detect MAC387, vascular endothelial growth factor VEGF and CD31 expression. |
98) Transforming growth factor alpha (TGFα) and TGFβ1 are |
99) cells, platelet-rich plasma (PRP) as the growth factor and hyaluronic acid (HA) as |
100) s through effects on vascular endothelial growth factor and induction of apoptosis. |
101) it can be assumed that these transforming growth factor beta (TGFβ) superfamily fac |
102) , Myocilin (MYOC) and latent-transforming growth factor beta-binding protein 2 (LTBP |
|